...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides.
【24h】

Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides.

机译:3-氨基-N-苯基-1H-吲唑-1-羧酰胺的合成及其抗增殖活性。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of new 3-amino-N-phenyl-1H-indazole-1-carboxamides 10 have been prepared from commercially available phenyl isocyanate precursors 8 and 3-aminoindazole 9. Some of the synthesized compounds were evaluated for their in vitro antineoplastic activity against 60 human cell lines derived from seven clinically isolated cancer types (lung, colon, melanoma, renal, ovarian, brain, and leukemia) according to the NCI standard protocol. The test results indicated that 3-amino-1H-indazole-1-carboxamides 10 were endowed with an interesting antiproliferative activity. The most active compounds of this series, 10d,e, were able to inhibit cell growth of many neoplastic cell lines at concentrations lower than 1 microM (0.0153 microM in SR leukemia) causing a block in G0-G1 phase of cell cycle. Analysis of pRb expression showed that these two compounds increased the ratio between underphosphorylated pRb and total pRb. The X-ray structure of 10w, confirmed the 3-amino-N-phenyl-1H-indazole-1-carboxamide structure of compounds 10.
机译:由市售的苯基异氰酸酯前体8和3-氨基吲唑9制备了一系列新的3-氨基-N-苯基-1H-吲唑-1-羧酰胺10。对其中一些合成化合物的体外抗肿瘤活性进行了评估。根据NCI标准规程,从七种临床分离的癌症类型(肺癌,结肠癌,黑色素瘤,肾癌,卵巢癌,脑癌和白血病)衍生出60种人类细胞系。测试结果表明3-氨基-1H-吲唑-1-羧酰胺10具有令人感兴趣的抗增殖活性。该系列中活性最高的化合物10d,e能够以低于1 microM的浓度(在SR白血病中为0.0153 microM)抑制许多肿瘤细胞系的细胞生长,从而导致细胞周期的G0-G1期受阻。对pRb表达的分析表明,这两种化合物增加了磷酸化不足的pRb与总pRb之间的比率。 X射线结构为10w,证实了化合物10的3-氨基-N-苯基-1H-吲唑-1-羧酰胺结构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号